{
    "nctId": "NCT00762294",
    "briefTitle": "Anastrozole and Letrozole",
    "officialTitle": "Effect Of Anastrozole And Letrozole On Bone Turnover Markers And Bone Mineral Density In Postmenopausal Women With Primary Breast Cancer: A Pilot Study",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 25,
    "primaryOutcomeMeasure": "bone density",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Postmenopausal women with diagnosis of breast cancer - have not started Arimidex or Femara yet, but will be starting .\n\nExclusion Criteria:\n\n* History of metastasis\n* History of chronic kidney\n* Liver GI disease\n* Disorders affecting calcium metabolism",
    "sex": "FEMALE",
    "minimumAge": "40 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}